... companies' valuations. The return of mega funds and large institutional investors not only heightens competition for the best deals but also instills confidence in the sector regarding ongoing capital influx. Diversification of Investments: Fintech, Climate, Biotech (and even Crypto) on the Rise In 2025, venture investments are being distributed across an increasingly broad range of industries, extending beyond artificial intelligence alone. After last year’s downturn, there is a noticeable rebound in adjacent sectors — investors are once again ...

... demand for innovations in finance: companies offering businesses and consumers more efficient financial tools—from accounting automation to low-cost cross-border payments—are once again seen as growth drivers and commanding high multiples. Beyond AI: Biotech, Climate Technologies, and Other Sectors Although the hype surrounding AI dominates the headlines, venture financing in 2025 covers a much broader range of industries. Projects in biotechnology , medtech , climate technologies , and industrial software are regaining prominence. In the US and Asia, significant deals focusing on "green" agendas are being recorded: ...

... valuations. The return of mega funds and large institutional investors not only intensifies competition for the best deals but also instills confidence in the sector regarding the continued influx of capital. Diversification of Investments: Fintech, Climate, Biotech, and Even Crypto on the Rise In 2025, venture investments are being distributed across an increasingly broad range of industries, moving beyond merely artificial intelligence. Following last year's downturn, there is a noticeable revival in adjacent sectors—investors are once again ...

On Wednesday, June 18, 2025, the startup and venture capital markets are seeing a significant increase in attention to AI deals, defense technologies, and fund ecosystems. Investors are increasingly looking for new opportunities,... ... increases the availability of funding for startups around the world. M&A activity picks up: Pharma giant Eli Lilly is buying biotech startup Verve Therapeutics for up to $1.3 billion. Coupled with recent multi-billion dollar deals in the tech sector, ...

... company valuations. The return of mega funds and large institutional investors not only intensifies competition for the best deals but also instills confidence in the industry regarding future capital flows. Investment Diversification: Fintech, Climate, Biotech (and Even Crypto) on the Rise In 2025, venture investments are being distributed across an increasingly broad range of sectors, extending beyond artificial intelligence alone. Following last year's downturn, there is a noticeable revival in adjacent sectors — investors are once again ...